Stockscreener 앱 받기
36.30
4.31%
1.50
시간 외 거래:
36.30
전일 마감가:
$34.80
열려 있는:
$35.64
하루 거래량:
1.23M
Relative Volume:
2.61
시가총액:
$1.15B
수익:
$780.57M
순이익/손실:
$62.87M
주가수익비율:
21.14
EPS:
1.7171
순현금흐름:
$327.58M
1주 성능:
+3.71%
1개월 성능:
-19.65%
6개월 성능:
+1.54%
1년 성능:
+21.61%
1일 변동 폭
$34.67
$36.88
1주일 범위
$34.39
$37.06
52주 변동 폭
$23.23
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
36.30 | 1.11B | 780.57M | 62.87M | 327.58M | 1.7171 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 56.96B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 49.54B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.90B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.48B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.00 | 23.24B | 3.18B | 1.33B | 1.04B | 27.90 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Barclays reiterates Collegium Pharmaceutical stock rating at Overweight By Investing.com - Investing.com Canada
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap UpShould You Buy? - MarketBeat
Collegium Pharmaceutical to acquire Corium's ADHD drug for up to $785 million - marketscreener.com
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 - MarketBeat
Collegium Pharmaceutical to acquire AZSTARYS for $650 million By Investing.com - Investing.com Canada
Collegium Pharmaceutical to Acquire Azstarys From Corium Therapeutics for $650 Million in Cash - marketscreener.com
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory - Yahoo Finance
Fidelity lists 13,976 COLL shares for sale (NASDAQ: COLL) - Stock Titan
Whale Trades: What are analysts price targets for Collegium Pharmaceutical Inc2026 EndofMonth & Expert Curated Trade Setup Alerts - baoquankhu1.vn
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Member Spotlight: Collegium Pharmaceutical - Massachusetts Biotechnology Council
Collegium Pharmaceutical, Inc. $COLL Position Reduced by Eventide Asset Management LLC - MarketBeat
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference - MarketBeat
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure - Yahoo Finance
3 Healthcare Stocks Walking a Fine Line - The Globe and Mail
Insider Sell: David Dieter Sells Shares of Collegium Pharmaceuti - GuruFocus
Risk Recap: What is the dividend yield of Collegium Pharmaceutical IncIndex Update & Weekly Setup with ROI Potential - baoquankhu1.vn
Collegium (NASDAQ: COLL) EVP sells 6,224 shares under 10b5-1 plan - Stock Titan
Collegium Pharmaceutical at Barclays Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
WINTON GROUP Ltd Purchases Shares of 65,345 Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Victory Capital Management Inc. Cuts Stock Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results - Insider Monkey
Jefferies Financial Group Inc. Takes $4.43 Million Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Assessing Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Weakness - simplywall.st
[144] COLLEGIUM PHARMACEUTICAL, INC SEC Filing - Stock Titan
Market Catalysts: Can Collegium Pharmaceutical Inc be the next market leaderMarket Movers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Collegium Pharmaceutical, Inc. (COLL) gains momentum on Jornay PM, Truist highlights robust pain portfolio - MSN
Dow Update: Will Collegium Pharmaceutical Inc benefit from green energy policiesTrade Volume Report & Smart Money Movement Alerts - baoquankhu1.vn
(COLL) Volatility Zones as Tactical Triggers - Stock Traders Daily
Pharma News: Can Collegium Pharmaceutical Inc benefit from deglobalizationQuarterly Market Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Citigroup Inc. Decreases Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Insider Sell: Scott Dreyer Sells 49,976 Shares of Collegium Phar - GuruFocus
Scott Dreyer Sells 49,976 Shares of Collegium Pharmaceutical (NASDAQ:COLL) Stock - MarketBeat
Collegium to Present New Real-World Data at PainConnect 2026 - The Manila Times
Quantbot Technologies LP Has $1.79 Million Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle' - Fierce Pharma
49,976 COLL shares flagged for sale (NASDAQ: COLL) - Stock Titan
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign - TipRanks
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community - Nasdaq
Paris Hilton Shares Her Experience with JORNAY PM and - GlobeNewswire
Collegium Pharmaceutical Faces Weak Start with 8.74% Gap Down Amid Market Concerns - Markets Mojo
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Momentum Shift: Does Collegium Pharmaceutical Inc offer margin of safety2025 Pullback Review & Weekly High Return Stock Forecasts - baoquankhu1.vn
Can Collegium Pharmaceutical Inc be the next market leaderMarket Growth Report & Reliable Price Breakout Signals - baoquankhu1.vn
Collegium to Participate in Upcoming Investor Conferences - The Manila Times
Aug EndMonth: What are analysts price targets for Collegium Pharmaceutical IncShort Setup & Growth Oriented Trading Recommendations - baoquankhu1.vn
Collegium Pharmaceutical, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:COLL) 2026-03-01 - Seeking Alpha
A Look At Collegium Pharmaceutical (COLL) Valuation After Mixed Q4 2025 Results And Updated 2026 Guidance - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss - Yahoo Finance
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today - Finviz
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.77%
자본화:
|
볼륨(24시간):